2x founder
Yongjin Park
Founder at 1849 bio (YC S24)
Experience
Career
20241849 bio
FounderFounder, CSO · San Francisco Bay Area · 2024 – Present
2023Pivot Bio
Scientist III, Technical Project Lead · Berkeley, California, United States · 2023 – 2024
2021Pivot Bio
Scientist II · Berkeley, California, United States · 2021 – 2023
2020Pivot Bio
Scientist I · Berkeley, California, United States · 2020 – 2021
- 2020
Empress Therapeutics
FounderSynthetic Biology Consultant · Cambridge, Massachusetts, United States · 2020 – 2022
2019Zymergen, Inc.
Scientist I · Emeryville, California · 2019 – 2020
2019Massachusetts Institute of Technology
Postdoctoral Researcher · 2019
2012Massachusetts Institute of Technology
Ph.D. candidate · 500 Technology Sq · 2012 – 2019
2008Korea Advanced Institute of Science and Technology
Bachelor of Science · Daedeok-gu, Daejeon, Korea · 2008 – 2012
2010Harvard Medical School
Research Assistant · Cambridge, Massachusetts, United States · 2010 – 2011
Bio
I am the co-founder and CSO of 1849 bio. I studied chemical engineering at KAIST and did my PhD at MIT in the Department of Biological Engineering. During my PhD, I developed core technology used in the world's first engineered probiotic that went into clinical trial. After completing PhD, I worked in deep biotech companies, developing microbial products that were administered to over 6M acres of farmland in the US (about the area of Belgium!).